PANX1-mediated NLRP3 inflammasome activation promotes an adaptive doxorubicin resistance through IL-1beta signaling in breast cancer. Yang C, Liu J, Kang X, Wang Z, et al. Cancer Lett 2026;645:218387.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang C, Liu J, Kang X, Wang Z, et al. PANX1-mediated NLRP3 inflammasome activation promotes an adaptive doxorubicin resistance through IL-1beta signaling in breast cancer. Cancer Lett 2026;645:218387.
PMID: 41765358